nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—GSS—Trans-sulfuration and one carbon metabolism—DNMT3L—testicular cancer	0.0479	0.103	CbGpPWpGaD
Acetylcysteine—GSS—Glutathione conjugation—HPGDS—testicular cancer	0.0229	0.0491	CbGpPWpGaD
Acetylcysteine—CHUK—Validated transcriptional targets of TAp63 isoforms—TFAP2C—testicular cancer	0.0165	0.0353	CbGpPWpGaD
Acetylcysteine—IKBKB—Validated transcriptional targets of TAp63 isoforms—TFAP2C—testicular cancer	0.015	0.032	CbGpPWpGaD
Acetylcysteine—SLC7A11—NRF2 pathway—SLC2A6—testicular cancer	0.0146	0.0312	CbGpPWpGaD
Acetylcysteine—ACY1—testis—testicular cancer	0.014	0.0843	CbGeAlD
Acetylcysteine—IKBKB—embryo—testicular cancer	0.0134	0.0808	CbGeAlD
Acetylcysteine—GSS—seminal vesicle—testicular cancer	0.0123	0.0745	CbGeAlD
Acetylcysteine—CHUK—Canonical NF-kappaB pathway—BCL10—testicular cancer	0.0121	0.0259	CbGpPWpGaD
Acetylcysteine—CHUK—FCERI mediated NF-kB activation—BCL10—testicular cancer	0.0121	0.0259	CbGpPWpGaD
Acetylcysteine—IKBKB—FCERI mediated NF-kB activation—BCL10—testicular cancer	0.011	0.0235	CbGpPWpGaD
Acetylcysteine—IKBKB—Canonical NF-kappaB pathway—BCL10—testicular cancer	0.011	0.0235	CbGpPWpGaD
Acetylcysteine—CHUK—female gonad—testicular cancer	0.0109	0.0656	CbGeAlD
Acetylcysteine—ACY1—Biological oxidations—HPGDS—testicular cancer	0.0104	0.0223	CbGpPWpGaD
Acetylcysteine—GSS—Phase II conjugation—HPGDS—testicular cancer	0.0102	0.0219	CbGpPWpGaD
Acetylcysteine—GRIN2D—testis—testicular cancer	0.00989	0.0597	CbGeAlD
Acetylcysteine—CHUK—testis—testicular cancer	0.00964	0.0582	CbGeAlD
Acetylcysteine—GRIN3A—testis—testicular cancer	0.0093	0.0561	CbGeAlD
Acetylcysteine—SLC7A11—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.0092	0.0197	CbGpPWpGaD
Acetylcysteine—IKBKB—gonad—testicular cancer	0.00909	0.0549	CbGeAlD
Acetylcysteine—SLC7A11—female gonad—testicular cancer	0.00895	0.054	CbGeAlD
Acetylcysteine—GSS—gonad—testicular cancer	0.00892	0.0539	CbGeAlD
Acetylcysteine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00871	0.0186	CbGpPWpGaD
Acetylcysteine—SLC7A11—testis—testicular cancer	0.00794	0.0479	CbGeAlD
Acetylcysteine—Throat tightness—Etoposide—testicular cancer	0.00769	0.021	CcSEcCtD
Acetylcysteine—CHUK—Downstream TCR signaling—BCL10—testicular cancer	0.00761	0.0163	CbGpPWpGaD
Acetylcysteine—IKBKB—female gonad—testicular cancer	0.00739	0.0446	CbGeAlD
Acetylcysteine—GRIN2A—testis—testicular cancer	0.00735	0.0444	CbGeAlD
Acetylcysteine—GSS—female gonad—testicular cancer	0.00725	0.0438	CbGeAlD
Acetylcysteine—CHUK—lymph node—testicular cancer	0.00699	0.0422	CbGeAlD
Acetylcysteine—IKBKB—Downstream TCR signaling—BCL10—testicular cancer	0.0069	0.0148	CbGpPWpGaD
Acetylcysteine—IKBKB—testis—testicular cancer	0.00655	0.0395	CbGeAlD
Acetylcysteine—GSS—testis—testicular cancer	0.00643	0.0388	CbGeAlD
Acetylcysteine—CHUK—TCR signaling in naïve CD8+ T cells—BCL10—testicular cancer	0.0062	0.0133	CbGpPWpGaD
Acetylcysteine—GSS—Biological oxidations—HPGDS—testicular cancer	0.00598	0.0128	CbGpPWpGaD
Acetylcysteine—Sensitisation—Epirubicin—testicular cancer	0.00592	0.0161	CcSEcCtD
Acetylcysteine—CHUK—TCR signaling—BCL10—testicular cancer	0.00569	0.0122	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR signaling in naïve CD8+ T cells—BCL10—testicular cancer	0.00562	0.012	CbGpPWpGaD
Acetylcysteine—Sensitisation—Doxorubicin—testicular cancer	0.00548	0.0149	CcSEcCtD
Acetylcysteine—Wheezing—Bleomycin—testicular cancer	0.00543	0.0148	CcSEcCtD
Acetylcysteine—CHUK—Activation of NF-kappaB in B cells—BCL10—testicular cancer	0.00526	0.0113	CbGpPWpGaD
Acetylcysteine—CHUK—TCR signaling in naïve CD4+ T cells—BCL10—testicular cancer	0.0052	0.0111	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR signaling—BCL10—testicular cancer	0.00516	0.011	CbGpPWpGaD
Acetylcysteine—CHUK—BCR signaling pathway—BCL10—testicular cancer	0.00514	0.011	CbGpPWpGaD
Acetylcysteine—Rhinorrhoea—Cisplatin—testicular cancer	0.00508	0.0139	CcSEcCtD
Acetylcysteine—Gait disturbance—Ifosfamide—testicular cancer	0.00489	0.0133	CcSEcCtD
Acetylcysteine—IKBKB—Activation of NF-kappaB in B cells—BCL10—testicular cancer	0.00477	0.0102	CbGpPWpGaD
Acetylcysteine—IKBKB—lymph node—testicular cancer	0.00475	0.0287	CbGeAlD
Acetylcysteine—IKBKB—TCR signaling in naïve CD4+ T cells—BCL10—testicular cancer	0.00472	0.0101	CbGpPWpGaD
Acetylcysteine—SLC7A11—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00468	0.01	CbGpPWpGaD
Acetylcysteine—GSS—lymph node—testicular cancer	0.00466	0.0281	CbGeAlD
Acetylcysteine—IKBKB—BCR signaling pathway—BCL10—testicular cancer	0.00466	0.00997	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—PRDM14—testicular cancer	0.00466	0.00997	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—PRDM14—testicular cancer	0.00454	0.00972	CbGpPWpGaD
Acetylcysteine—Chest discomfort—Etoposide—testicular cancer	0.00426	0.0116	CcSEcCtD
Acetylcysteine—CHUK—TCR Signaling Pathway—BCL10—testicular cancer	0.00406	0.00868	CbGpPWpGaD
Acetylcysteine—Wheezing—Cisplatin—testicular cancer	0.004	0.0109	CcSEcCtD
Acetylcysteine—Body temperature increased—Carboplatin—testicular cancer	0.00396	0.0108	CcSEcCtD
Acetylcysteine—SLC22A6—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00396	0.00847	CbGpPWpGaD
Acetylcysteine—Stomatitis—Chlorambucil—testicular cancer	0.00394	0.0107	CcSEcCtD
Acetylcysteine—CHUK—B Cell Receptor Signaling Pathway—BCL10—testicular cancer	0.00382	0.00818	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR Signaling Pathway—BCL10—testicular cancer	0.00368	0.00787	CbGpPWpGaD
Acetylcysteine—SLCO1B1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.0036	0.0077	CbGpPWpGaD
Acetylcysteine—CHUK—Osteopontin-mediated events—MMP2—testicular cancer	0.00347	0.00743	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Receptor Signaling Pathway—BCL10—testicular cancer	0.00347	0.00742	CbGpPWpGaD
Acetylcysteine—Bronchospasm—Bleomycin—testicular cancer	0.00345	0.0094	CcSEcCtD
Acetylcysteine—Pharyngitis—Vinblastine—testicular cancer	0.0033	0.00899	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Cisplatin—testicular cancer	0.00309	0.00842	CcSEcCtD
Acetylcysteine—Stomatitis—Bleomycin—testicular cancer	0.00305	0.0083	CcSEcCtD
Acetylcysteine—Bronchospasm—Ifosfamide—testicular cancer	0.00295	0.00803	CcSEcCtD
Acetylcysteine—Face oedema—Cisplatin—testicular cancer	0.00289	0.00786	CcSEcCtD
Acetylcysteine—Angioedema—Chlorambucil—testicular cancer	0.00289	0.00786	CcSEcCtD
Acetylcysteine—Haemoptysis—Epirubicin—testicular cancer	0.00286	0.00779	CcSEcCtD
Acetylcysteine—Stomatitis—Dactinomycin—testicular cancer	0.00284	0.00775	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Etoposide—testicular cancer	0.00283	0.00771	CcSEcCtD
Acetylcysteine—Feeling hot—Epirubicin—testicular cancer	0.00269	0.00734	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Cisplatin—testicular cancer	0.00267	0.00728	CcSEcCtD
Acetylcysteine—Haemoptysis—Doxorubicin—testicular cancer	0.00264	0.0072	CcSEcCtD
Acetylcysteine—Flushing—Bleomycin—testicular cancer	0.00261	0.0071	CcSEcCtD
Acetylcysteine—Stomatitis—Ifosfamide—testicular cancer	0.00261	0.0071	CcSEcCtD
Acetylcysteine—Pharyngitis—Dactinomycin—testicular cancer	0.0026	0.00708	CcSEcCtD
Acetylcysteine—CHUK—Constitutive PI3K/AKT Signaling in Cancer—KITLG—testicular cancer	0.00254	0.00543	CbGpPWpGaD
Acetylcysteine—Feeling hot—Doxorubicin—testicular cancer	0.00249	0.00679	CcSEcCtD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—BCL10—testicular cancer	0.00247	0.0053	CbGpPWpGaD
Acetylcysteine—Erythema—Bleomycin—testicular cancer	0.00244	0.00666	CcSEcCtD
Acetylcysteine—Flushing—Dactinomycin—testicular cancer	0.00243	0.00662	CcSEcCtD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—BCL10—testicular cancer	0.00236	0.00505	CbGpPWpGaD
Acetylcysteine—Bronchospasm—Etoposide—testicular cancer	0.00233	0.00634	CcSEcCtD
Acetylcysteine—Thinking abnormal—Epirubicin—testicular cancer	0.00231	0.00629	CcSEcCtD
Acetylcysteine—CHUK—PI-3K cascade—KITLG—testicular cancer	0.00229	0.00489	CbGpPWpGaD
Acetylcysteine—Erythema—Dactinomycin—testicular cancer	0.00228	0.00621	CcSEcCtD
Acetylcysteine—Dyspepsia—Chlorambucil—testicular cancer	0.00227	0.00618	CcSEcCtD
Acetylcysteine—Stomatitis—Cisplatin—testicular cancer	0.00225	0.00612	CcSEcCtD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—BCL10—testicular cancer	0.00224	0.0048	CbGpPWpGaD
Acetylcysteine—CHUK—PI3K/AKT activation—KITLG—testicular cancer	0.00223	0.00477	CbGpPWpGaD
Acetylcysteine—Flushing—Ifosfamide—testicular cancer	0.00223	0.00607	CcSEcCtD
Acetylcysteine—Cardiac disorder—Ifosfamide—testicular cancer	0.00223	0.00607	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.00222	0.00606	CcSEcCtD
Acetylcysteine—CHUK—GAB1 signalosome—KITLG—testicular cancer	0.00221	0.00474	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—BCL10—testicular cancer	0.00219	0.00468	CbGpPWpGaD
Acetylcysteine—Angiopathy—Ifosfamide—testicular cancer	0.00218	0.00593	CcSEcCtD
Acetylcysteine—Gait disturbance—Epirubicin—testicular cancer	0.00217	0.0059	CcSEcCtD
Acetylcysteine—Immune system disorder—Ifosfamide—testicular cancer	0.00217	0.0059	CcSEcCtD
Acetylcysteine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—KITLG—testicular cancer	0.00216	0.00463	CbGpPWpGaD
Acetylcysteine—Mediastinal disorder—Ifosfamide—testicular cancer	0.00216	0.00589	CcSEcCtD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—BCL10—testicular cancer	0.00214	0.00458	CbGpPWpGaD
Acetylcysteine—Thinking abnormal—Doxorubicin—testicular cancer	0.00214	0.00582	CcSEcCtD
Acetylcysteine—Cough—Bleomycin—testicular cancer	0.00213	0.00581	CcSEcCtD
Acetylcysteine—GRIN1—EPH-Ephrin signaling—MMP2—testicular cancer	0.00211	0.00452	CbGpPWpGaD
Acetylcysteine—Erythema—Ifosfamide—testicular cancer	0.00209	0.00569	CcSEcCtD
Acetylcysteine—GRIN2B—EPH-Ephrin signaling—MMP2—testicular cancer	0.00206	0.00441	CbGpPWpGaD
Acetylcysteine—Stomatitis—Etoposide—testicular cancer	0.00206	0.00561	CcSEcCtD
Acetylcysteine—Urticaria—Chlorambucil—testicular cancer	0.00205	0.00558	CcSEcCtD
Acetylcysteine—Body temperature increased—Chlorambucil—testicular cancer	0.00204	0.00555	CcSEcCtD
Acetylcysteine—SLC22A6—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00201	0.0043	CbGpPWpGaD
Acetylcysteine—Gait disturbance—Doxorubicin—testicular cancer	0.00201	0.00546	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Bleomycin—testicular cancer	0.00199	0.00543	CcSEcCtD
Acetylcysteine—Oedema—Bleomycin—testicular cancer	0.00199	0.00543	CcSEcCtD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.00199	0.00427	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—BCL10—testicular cancer	0.00198	0.00424	CbGpPWpGaD
Acetylcysteine—Flushing—Cisplatin—testicular cancer	0.00192	0.00523	CcSEcCtD
Acetylcysteine—Cardiac disorder—Cisplatin—testicular cancer	0.00192	0.00523	CcSEcCtD
Acetylcysteine—Angioedema—Ifosfamide—testicular cancer	0.00191	0.0052	CcSEcCtD
Acetylcysteine—Hypersensitivity—Chlorambucil—testicular cancer	0.0019	0.00517	CcSEcCtD
Acetylcysteine—CHUK—AGE/RAGE pathway—MMP2—testicular cancer	0.0019	0.00406	CbGpPWpGaD
Acetylcysteine—CHUK—Constitutive PI3K/AKT Signaling in Cancer—FGFR3—testicular cancer	0.00189	0.00404	CbGpPWpGaD
Acetylcysteine—Immune system disorder—Cisplatin—testicular cancer	0.00187	0.00509	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Cisplatin—testicular cancer	0.00186	0.00508	CcSEcCtD
Acetylcysteine—Hypotension—Bleomycin—testicular cancer	0.00186	0.00508	CcSEcCtD
Acetylcysteine—Oedema—Dactinomycin—testicular cancer	0.00186	0.00507	CcSEcCtD
Acetylcysteine—Mental disability—Epirubicin—testicular cancer	0.00184	0.005	CcSEcCtD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00183	0.00391	CbGpPWpGaD
Acetylcysteine—Pruritus—Chlorambucil—testicular cancer	0.00182	0.00497	CcSEcCtD
Acetylcysteine—Cough—Ifosfamide—testicular cancer	0.00182	0.00497	CcSEcCtD
Acetylcysteine—Erythema—Cisplatin—testicular cancer	0.0018	0.00491	CcSEcCtD
Acetylcysteine—ACY1—Metabolism—HPGDS—testicular cancer	0.00178	0.00381	CbGpPWpGaD
Acetylcysteine—Dyspnoea—Bleomycin—testicular cancer	0.00178	0.00484	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.00177	0.00481	CcSEcCtD
Acetylcysteine—Cardiac disorder—Etoposide—testicular cancer	0.00176	0.00479	CcSEcCtD
Acetylcysteine—Flushing—Etoposide—testicular cancer	0.00176	0.00479	CcSEcCtD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—STK11—testicular cancer	0.00175	0.00374	CbGpPWpGaD
Acetylcysteine—Hypersensitivity—Vinblastine—testicular cancer	0.00174	0.00474	CcSEcCtD
Acetylcysteine—CHUK—Constitutive PI3K/AKT Signaling in Cancer—KIT—testicular cancer	0.00173	0.00371	CbGpPWpGaD
Acetylcysteine—Angiopathy—Etoposide—testicular cancer	0.00172	0.00468	CcSEcCtD
Acetylcysteine—IKBKB—AGE/RAGE pathway—MMP2—testicular cancer	0.00172	0.00368	CbGpPWpGaD
Acetylcysteine—Immune system disorder—Etoposide—testicular cancer	0.00171	0.00466	CcSEcCtD
Acetylcysteine—CHUK—Signaling by SCF-KIT—KITLG—testicular cancer	0.00171	0.00366	CbGpPWpGaD
Acetylcysteine—Mediastinal disorder—Etoposide—testicular cancer	0.00171	0.00465	CcSEcCtD
Acetylcysteine—Oedema—Ifosfamide—testicular cancer	0.0017	0.00464	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Ifosfamide—testicular cancer	0.0017	0.00464	CcSEcCtD
Acetylcysteine—Eye pain—Epirubicin—testicular cancer	0.0017	0.00463	CcSEcCtD
Acetylcysteine—CHUK—PI-3K cascade—FGFR3—testicular cancer	0.0017	0.00364	CbGpPWpGaD
Acetylcysteine—Mental disability—Doxorubicin—testicular cancer	0.0017	0.00463	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Methotrexate—testicular cancer	0.0017	0.00462	CcSEcCtD
Acetylcysteine—CHUK—PI3K/AKT activation—FGFR3—testicular cancer	0.00166	0.00355	CbGpPWpGaD
Acetylcysteine—Skin disorder—Ifosfamide—testicular cancer	0.00166	0.00451	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Ifosfamide—testicular cancer	0.00165	0.00449	CcSEcCtD
Acetylcysteine—CHUK—GAB1 signalosome—FGFR3—testicular cancer	0.00165	0.00352	CbGpPWpGaD
Acetylcysteine—Vomiting—Chlorambucil—testicular cancer	0.00164	0.00446	CcSEcCtD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—KITLG—testicular cancer	0.00163	0.0035	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—KITLG—testicular cancer	0.00161	0.00344	CbGpPWpGaD
Acetylcysteine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—FGFR3—testicular cancer	0.00161	0.00344	CbGpPWpGaD
Acetylcysteine—Hypotension—Ifosfamide—testicular cancer	0.00159	0.00434	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Epirubicin—testicular cancer	0.00159	0.00432	CcSEcCtD
Acetylcysteine—Urticaria—Bleomycin—testicular cancer	0.00158	0.00432	CcSEcCtD
Acetylcysteine—Body temperature increased—Bleomycin—testicular cancer	0.00158	0.0043	CcSEcCtD
Acetylcysteine—Eye pain—Doxorubicin—testicular cancer	0.00157	0.00429	CcSEcCtD
Acetylcysteine—Dizziness—Vinblastine—testicular cancer	0.00156	0.00425	CcSEcCtD
Acetylcysteine—CHUK—PI-3K cascade—KIT—testicular cancer	0.00156	0.00334	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—KITLG—testicular cancer	0.00154	0.00329	CbGpPWpGaD
Acetylcysteine—Nausea—Chlorambucil—testicular cancer	0.00153	0.00417	CcSEcCtD
Acetylcysteine—CHUK—Signaling by FGFR—KITLG—testicular cancer	0.00153	0.00327	CbGpPWpGaD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00152	0.00415	CcSEcCtD
Acetylcysteine—CHUK—PI3K/AKT activation—KIT—testicular cancer	0.00152	0.00326	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—KITLG—testicular cancer	0.00152	0.00326	CbGpPWpGaD
Acetylcysteine—Dyspnoea—Ifosfamide—testicular cancer	0.00152	0.00414	CcSEcCtD
Acetylcysteine—Somnolence—Ifosfamide—testicular cancer	0.00152	0.00413	CcSEcCtD
Acetylcysteine—CHUK—DAP12 signaling—KITLG—testicular cancer	0.00151	0.00324	CbGpPWpGaD
Acetylcysteine—CHUK—GAB1 signalosome—KIT—testicular cancer	0.00151	0.00323	CbGpPWpGaD
Acetylcysteine—Vomiting—Vinblastine—testicular cancer	0.0015	0.00409	CcSEcCtD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—KITLG—testicular cancer	0.00149	0.00319	CbGpPWpGaD
Acetylcysteine—Face oedema—Epirubicin—testicular cancer	0.00148	0.00404	CcSEcCtD
Acetylcysteine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—KIT—testicular cancer	0.00148	0.00316	CbGpPWpGaD
Acetylcysteine—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00147	0.00401	CcSEcCtD
Acetylcysteine—Body temperature increased—Dactinomycin—testicular cancer	0.00147	0.00401	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Cisplatin—testicular cancer	0.00147	0.004	CcSEcCtD
Acetylcysteine—Oedema—Cisplatin—testicular cancer	0.00147	0.004	CcSEcCtD
Acetylcysteine—Hypersensitivity—Bleomycin—testicular cancer	0.00147	0.004	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.00147	0.004	CcSEcCtD
Acetylcysteine—Loss of consciousness—Etoposide—testicular cancer	0.00145	0.00395	CcSEcCtD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.00145	0.0031	CbGpPWpGaD
Acetylcysteine—Cough—Etoposide—testicular cancer	0.00144	0.00392	CcSEcCtD
Acetylcysteine—Tachycardia—Cisplatin—testicular cancer	0.00143	0.00391	CcSEcCtD
Acetylcysteine—Skin disorder—Cisplatin—testicular cancer	0.00143	0.00389	CcSEcCtD
Acetylcysteine—CHUK—DAP12 interactions—KITLG—testicular cancer	0.00142	0.00305	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	0.00142	0.00305	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—KITLG—testicular cancer	0.00142	0.00305	CbGpPWpGaD
Acetylcysteine—Hyperhidrosis—Cisplatin—testicular cancer	0.00142	0.00387	CcSEcCtD
Acetylcysteine—Asthma—Methotrexate—testicular cancer	0.00142	0.00386	CcSEcCtD
Acetylcysteine—CHUK—Signaling by EGFR—KITLG—testicular cancer	0.00141	0.00302	CbGpPWpGaD
Acetylcysteine—Pruritus—Bleomycin—testicular cancer	0.00141	0.00384	CcSEcCtD
Acetylcysteine—Nausea—Vinblastine—testicular cancer	0.0014	0.00382	CcSEcCtD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—KITLG—testicular cancer	0.0014	0.00299	CbGpPWpGaD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00139	0.0038	CcSEcCtD
Acetylcysteine—CHUK—Signaling by PDGF—KITLG—testicular cancer	0.00139	0.00298	CbGpPWpGaD
Acetylcysteine—Hypotension—Cisplatin—testicular cancer	0.00137	0.00374	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Epirubicin—testicular cancer	0.00137	0.00374	CcSEcCtD
Acetylcysteine—Face oedema—Doxorubicin—testicular cancer	0.00137	0.00374	CcSEcCtD
Acetylcysteine—Hypersensitivity—Dactinomycin—testicular cancer	0.00137	0.00373	CcSEcCtD
Acetylcysteine—Urticaria—Ifosfamide—testicular cancer	0.00135	0.00369	CcSEcCtD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KITLG—testicular cancer	0.00135	0.0029	CbGpPWpGaD
Acetylcysteine—Body temperature increased—Ifosfamide—testicular cancer	0.00135	0.00367	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Etoposide—testicular cancer	0.00135	0.00367	CcSEcCtD
Acetylcysteine—Asthma—Epirubicin—testicular cancer	0.00133	0.00362	CcSEcCtD
Acetylcysteine—CHUK—B Cell Activation—KITLG—testicular cancer	0.00132	0.00282	CbGpPWpGaD
Acetylcysteine—Tachycardia—Etoposide—testicular cancer	0.00131	0.00358	CcSEcCtD
Acetylcysteine—Dyspnoea—Cisplatin—testicular cancer	0.00131	0.00357	CcSEcCtD
Acetylcysteine—Skin disorder—Etoposide—testicular cancer	0.00131	0.00356	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Etoposide—testicular cancer	0.0013	0.00355	CcSEcCtD
Acetylcysteine—ACY1—Metabolism—STK11—testicular cancer	0.00129	0.00277	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	0.00129	0.00276	CbGpPWpGaD
Acetylcysteine—Nasopharyngitis—Doxorubicin—testicular cancer	0.00127	0.00346	CcSEcCtD
Acetylcysteine—CHUK—Signaling by SCF-KIT—FGFR3—testicular cancer	0.00127	0.00272	CbGpPWpGaD
Acetylcysteine—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00127	0.00346	CcSEcCtD
Acetylcysteine—Vomiting—Bleomycin—testicular cancer	0.00127	0.00345	CcSEcCtD
Acetylcysteine—Drowsiness—Methotrexate—testicular cancer	0.00126	0.00344	CcSEcCtD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.00126	0.0027	CbGpPWpGaD
Acetylcysteine—Hypotension—Etoposide—testicular cancer	0.00126	0.00343	CcSEcCtD
Acetylcysteine—Rash—Bleomycin—testicular cancer	0.00126	0.00343	CcSEcCtD
Acetylcysteine—Dermatitis—Bleomycin—testicular cancer	0.00126	0.00342	CcSEcCtD
Acetylcysteine—Hypersensitivity—Ifosfamide—testicular cancer	0.00126	0.00342	CcSEcCtD
Acetylcysteine—Stomatitis—Methotrexate—testicular cancer	0.00123	0.00336	CcSEcCtD
Acetylcysteine—Asthma—Doxorubicin—testicular cancer	0.00123	0.00335	CcSEcCtD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—FGFR3—testicular cancer	0.00121	0.0026	CbGpPWpGaD
Acetylcysteine—Sweating—Methotrexate—testicular cancer	0.00121	0.0033	CcSEcCtD
Acetylcysteine—Pruritus—Ifosfamide—testicular cancer	0.00121	0.00329	CcSEcCtD
Acetylcysteine—Dyspnoea—Etoposide—testicular cancer	0.0012	0.00327	CcSEcCtD
Acetylcysteine—Somnolence—Etoposide—testicular cancer	0.0012	0.00326	CcSEcCtD
Acetylcysteine—CHUK—Signaling by ERBB4—FGFR3—testicular cancer	0.0012	0.00256	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—KITLG—testicular cancer	0.0012	0.00256	CbGpPWpGaD
Acetylcysteine—Nausea—Bleomycin—testicular cancer	0.00118	0.00323	CcSEcCtD
Acetylcysteine—Drowsiness—Epirubicin—testicular cancer	0.00118	0.00322	CcSEcCtD
Acetylcysteine—Vomiting—Dactinomycin—testicular cancer	0.00118	0.00322	CcSEcCtD
Acetylcysteine—Rash—Dactinomycin—testicular cancer	0.00117	0.0032	CcSEcCtD
Acetylcysteine—CHUK—Signaling by SCF-KIT—KIT—testicular cancer	0.00117	0.00249	CbGpPWpGaD
Acetylcysteine—Gastrointestinal disorder—Etoposide—testicular cancer	0.00116	0.00317	CcSEcCtD
Acetylcysteine—Body temperature increased—Cisplatin—testicular cancer	0.00116	0.00316	CcSEcCtD
Acetylcysteine—Stomatitis—Epirubicin—testicular cancer	0.00115	0.00314	CcSEcCtD
Acetylcysteine—CHUK—Downstream signal transduction—FGFR3—testicular cancer	0.00114	0.00244	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—FGFR3—testicular cancer	0.00114	0.00243	CbGpPWpGaD
Acetylcysteine—Sweating—Epirubicin—testicular cancer	0.00113	0.00309	CcSEcCtD
Acetylcysteine—CHUK—Signaling by ERBB2—FGFR3—testicular cancer	0.00113	0.00242	CbGpPWpGaD
Acetylcysteine—Dizziness—Ifosfamide—testicular cancer	0.00113	0.00307	CcSEcCtD
Acetylcysteine—Pharyngitis—Methotrexate—testicular cancer	0.00113	0.00307	CcSEcCtD
Acetylcysteine—CHUK—DAP12 signaling—FGFR3—testicular cancer	0.00113	0.00241	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—KIT—testicular cancer	0.00112	0.00239	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—testicular cancer	0.00111	0.00237	CbGpPWpGaD
Acetylcysteine—Nausea—Dactinomycin—testicular cancer	0.0011	0.00301	CcSEcCtD
Acetylcysteine—CHUK—Signaling by ERBB4—KIT—testicular cancer	0.0011	0.00235	CbGpPWpGaD
Acetylcysteine—Drowsiness—Doxorubicin—testicular cancer	0.00109	0.00298	CcSEcCtD
Acetylcysteine—Vomiting—Ifosfamide—testicular cancer	0.00108	0.00295	CcSEcCtD
Acetylcysteine—Hypersensitivity—Cisplatin—testicular cancer	0.00108	0.00295	CcSEcCtD
Acetylcysteine—Rash—Ifosfamide—testicular cancer	0.00107	0.00293	CcSEcCtD
Acetylcysteine—Dermatitis—Ifosfamide—testicular cancer	0.00107	0.00293	CcSEcCtD
Acetylcysteine—Urticaria—Etoposide—testicular cancer	0.00107	0.00291	CcSEcCtD
Acetylcysteine—Stomatitis—Doxorubicin—testicular cancer	0.00107	0.00291	CcSEcCtD
Acetylcysteine—Body temperature increased—Etoposide—testicular cancer	0.00106	0.0029	CcSEcCtD
Acetylcysteine—CHUK—DAP12 interactions—FGFR3—testicular cancer	0.00106	0.00227	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.00106	0.00227	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—FGFR3—testicular cancer	0.00106	0.00227	CbGpPWpGaD
Acetylcysteine—Pharyngitis—Epirubicin—testicular cancer	0.00105	0.00287	CcSEcCtD
Acetylcysteine—Cardiac disorder—Methotrexate—testicular cancer	0.00105	0.00287	CcSEcCtD
Acetylcysteine—Sweating—Doxorubicin—testicular cancer	0.00105	0.00286	CcSEcCtD
Acetylcysteine—CHUK—Signaling by EGFR—FGFR3—testicular cancer	0.00105	0.00224	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—KIT—testicular cancer	0.00105	0.00224	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—KIT—testicular cancer	0.00104	0.00223	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—FGFR3—testicular cancer	0.00104	0.00223	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—KIT—testicular cancer	0.00104	0.00222	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—FGFR3—testicular cancer	0.00104	0.00222	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—KIT—testicular cancer	0.00103	0.00221	CbGpPWpGaD
Acetylcysteine—Angiopathy—Methotrexate—testicular cancer	0.00103	0.00281	CcSEcCtD
Acetylcysteine—Immune system disorder—Methotrexate—testicular cancer	0.00103	0.00279	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Methotrexate—testicular cancer	0.00102	0.00279	CcSEcCtD
Acetylcysteine—GSS—Metabolism—HPGDS—testicular cancer	0.00102	0.00219	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—KIT—testicular cancer	0.00102	0.00218	CbGpPWpGaD
Acetylcysteine—Nausea—Ifosfamide—testicular cancer	0.00101	0.00276	CcSEcCtD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—testicular cancer	0.00101	0.00215	CbGpPWpGaD
Acetylcysteine—Hypersensitivity—Etoposide—testicular cancer	0.000992	0.0027	CcSEcCtD
Acetylcysteine—Erythema—Methotrexate—testicular cancer	0.000988	0.00269	CcSEcCtD
Acetylcysteine—Cardiac disorder—Epirubicin—testicular cancer	0.000986	0.00269	CcSEcCtD
Acetylcysteine—Flushing—Epirubicin—testicular cancer	0.000986	0.00269	CcSEcCtD
Acetylcysteine—CHUK—B Cell Activation—FGFR3—testicular cancer	0.00098	0.0021	CbGpPWpGaD
Acetylcysteine—Pharyngitis—Doxorubicin—testicular cancer	0.000975	0.00266	CcSEcCtD
Acetylcysteine—CHUK—DAP12 interactions—KIT—testicular cancer	0.000972	0.00208	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—KIT—testicular cancer	0.000972	0.00208	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000972	0.00208	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—KITLG—testicular cancer	0.00097	0.00208	CbGpPWpGaD
Acetylcysteine—Angiopathy—Epirubicin—testicular cancer	0.000964	0.00263	CcSEcCtD
Acetylcysteine—CHUK—Signaling by EGFR—KIT—testicular cancer	0.000963	0.00206	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.00096	0.00205	CbGpPWpGaD
Acetylcysteine—Immune system disorder—Epirubicin—testicular cancer	0.000959	0.00261	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Epirubicin—testicular cancer	0.000957	0.00261	CcSEcCtD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—KIT—testicular cancer	0.000955	0.00204	CbGpPWpGaD
Acetylcysteine—Pruritus—Etoposide—testicular cancer	0.000952	0.00259	CcSEcCtD
Acetylcysteine—CHUK—Signaling by PDGF—KIT—testicular cancer	0.00095	0.00203	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000937	0.00201	CbGpPWpGaD
Acetylcysteine—Vomiting—Cisplatin—testicular cancer	0.000934	0.00255	CcSEcCtD
Acetylcysteine—Rash—Cisplatin—testicular cancer	0.000927	0.00252	CcSEcCtD
Acetylcysteine—Dermatitis—Cisplatin—testicular cancer	0.000926	0.00252	CcSEcCtD
Acetylcysteine—Erythema—Epirubicin—testicular cancer	0.000925	0.00252	CcSEcCtD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KIT—testicular cancer	0.000923	0.00198	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—BCL10—testicular cancer	0.000918	0.00196	CbGpPWpGaD
Acetylcysteine—Cardiac disorder—Doxorubicin—testicular cancer	0.000912	0.00249	CcSEcCtD
Acetylcysteine—Flushing—Doxorubicin—testicular cancer	0.000912	0.00249	CcSEcCtD
Acetylcysteine—CHUK—B Cell Activation—KIT—testicular cancer	0.000899	0.00192	CbGpPWpGaD
Acetylcysteine—Angiopathy—Doxorubicin—testicular cancer	0.000892	0.00243	CcSEcCtD
Acetylcysteine—Dizziness—Etoposide—testicular cancer	0.00089	0.00243	CcSEcCtD
Acetylcysteine—IKBKB—B Cell Activation—FGFR3—testicular cancer	0.000888	0.0019	CbGpPWpGaD
Acetylcysteine—Immune system disorder—Doxorubicin—testicular cancer	0.000888	0.00242	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Doxorubicin—testicular cancer	0.000886	0.00241	CcSEcCtD
Acetylcysteine—CHUK—Adaptive Immune System—BCL10—testicular cancer	0.000881	0.00189	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000881	0.00189	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—KITLG—testicular cancer	0.00088	0.00188	CbGpPWpGaD
Acetylcysteine—Nausea—Cisplatin—testicular cancer	0.000873	0.00238	CcSEcCtD
Acetylcysteine—Cough—Methotrexate—testicular cancer	0.000862	0.00235	CcSEcCtD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	0.000861	0.00184	CbGpPWpGaD
Acetylcysteine—Vomiting—Etoposide—testicular cancer	0.000856	0.00233	CcSEcCtD
Acetylcysteine—Erythema—Doxorubicin—testicular cancer	0.000856	0.00233	CcSEcCtD
Acetylcysteine—Rash—Etoposide—testicular cancer	0.000849	0.00231	CcSEcCtD
Acetylcysteine—Dermatitis—Etoposide—testicular cancer	0.000848	0.00231	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000835	0.00228	CcSEcCtD
Acetylcysteine—IKBKB—Innate Immune System—BCL10—testicular cancer	0.000832	0.00178	CbGpPWpGaD
Acetylcysteine—Syncope—Epirubicin—testicular cancer	0.000829	0.00226	CcSEcCtD
Acetylcysteine—IKBKB—B Cell Activation—KIT—testicular cancer	0.000816	0.00175	CbGpPWpGaD
Acetylcysteine—Loss of consciousness—Epirubicin—testicular cancer	0.000813	0.00221	CcSEcCtD
Acetylcysteine—Cough—Epirubicin—testicular cancer	0.000807	0.0022	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Methotrexate—testicular cancer	0.000806	0.0022	CcSEcCtD
Acetylcysteine—Nausea—Etoposide—testicular cancer	0.0008	0.00218	CcSEcCtD
Acetylcysteine—IKBKB—Adaptive Immune System—BCL10—testicular cancer	0.000799	0.00171	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—MMP2—testicular cancer	0.000785	0.00168	CbGpPWpGaD
Acetylcysteine—Skin disorder—Methotrexate—testicular cancer	0.000783	0.00213	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000782	0.00213	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Methotrexate—testicular cancer	0.00078	0.00212	CcSEcCtD
Acetylcysteine—Syncope—Doxorubicin—testicular cancer	0.000767	0.00209	CcSEcCtD
Acetylcysteine—GRIN2B—Axon guidance—MMP2—testicular cancer	0.000765	0.00164	CbGpPWpGaD
Acetylcysteine—Oedema—Epirubicin—testicular cancer	0.000755	0.00206	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Epirubicin—testicular cancer	0.000755	0.00206	CcSEcCtD
Acetylcysteine—Hypotension—Methotrexate—testicular cancer	0.000753	0.00205	CcSEcCtD
Acetylcysteine—Loss of consciousness—Doxorubicin—testicular cancer	0.000752	0.00205	CcSEcCtD
Acetylcysteine—Cough—Doxorubicin—testicular cancer	0.000747	0.00203	CcSEcCtD
Acetylcysteine—GSS—Metabolism—STK11—testicular cancer	0.000743	0.00159	CbGpPWpGaD
Acetylcysteine—Shock—Epirubicin—testicular cancer	0.000742	0.00202	CcSEcCtD
Acetylcysteine—Tachycardia—Epirubicin—testicular cancer	0.000736	0.00201	CcSEcCtD
Acetylcysteine—Skin disorder—Epirubicin—testicular cancer	0.000733	0.002	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Epirubicin—testicular cancer	0.00073	0.00199	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000723	0.00197	CcSEcCtD
Acetylcysteine—CHUK—Signaling by NGF—FGFR3—testicular cancer	0.000721	0.00154	CbGpPWpGaD
Acetylcysteine—Dyspnoea—Methotrexate—testicular cancer	0.000719	0.00196	CcSEcCtD
Acetylcysteine—Somnolence—Methotrexate—testicular cancer	0.000717	0.00195	CcSEcCtD
Acetylcysteine—Dyspepsia—Methotrexate—testicular cancer	0.00071	0.00193	CcSEcCtD
Acetylcysteine—CHUK—Signaling Pathways—INSL3—testicular cancer	0.000708	0.00151	CbGpPWpGaD
Acetylcysteine—Hypotension—Epirubicin—testicular cancer	0.000705	0.00192	CcSEcCtD
Acetylcysteine—Oedema—Doxorubicin—testicular cancer	0.000698	0.0019	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000698	0.0019	CcSEcCtD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000698	0.00149	CbGpPWpGaD
Acetylcysteine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000696	0.0019	CcSEcCtD
Acetylcysteine—Shock—Doxorubicin—testicular cancer	0.000687	0.00187	CcSEcCtD
Acetylcysteine—Tachycardia—Doxorubicin—testicular cancer	0.000681	0.00186	CcSEcCtD
Acetylcysteine—Skin disorder—Doxorubicin—testicular cancer	0.000678	0.00185	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000675	0.00184	CcSEcCtD
Acetylcysteine—Dyspnoea—Epirubicin—testicular cancer	0.000673	0.00183	CcSEcCtD
Acetylcysteine—Somnolence—Epirubicin—testicular cancer	0.000671	0.00183	CcSEcCtD
Acetylcysteine—Dyspepsia—Epirubicin—testicular cancer	0.000664	0.00181	CcSEcCtD
Acetylcysteine—CHUK—Signaling by NGF—KIT—testicular cancer	0.000662	0.00142	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—FGFR3—testicular cancer	0.000654	0.0014	CbGpPWpGaD
Acetylcysteine—Hypotension—Doxorubicin—testicular cancer	0.000652	0.00178	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000651	0.00177	CcSEcCtD
Acetylcysteine—IKBKB—Signaling Pathways—INSL3—testicular cancer	0.000642	0.00137	CbGpPWpGaD
Acetylcysteine—Urticaria—Methotrexate—testicular cancer	0.000641	0.00175	CcSEcCtD
Acetylcysteine—Body temperature increased—Methotrexate—testicular cancer	0.000637	0.00174	CcSEcCtD
Acetylcysteine—Dyspnoea—Doxorubicin—testicular cancer	0.000623	0.0017	CcSEcCtD
Acetylcysteine—Somnolence—Doxorubicin—testicular cancer	0.000621	0.00169	CcSEcCtD
Acetylcysteine—Dyspepsia—Doxorubicin—testicular cancer	0.000615	0.00167	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000603	0.00164	CcSEcCtD
Acetylcysteine—IKBKB—Signaling by NGF—KIT—testicular cancer	0.0006	0.00128	CbGpPWpGaD
Acetylcysteine—Urticaria—Epirubicin—testicular cancer	0.000599	0.00163	CcSEcCtD
Acetylcysteine—Body temperature increased—Epirubicin—testicular cancer	0.000597	0.00163	CcSEcCtD
Acetylcysteine—Hypersensitivity—Methotrexate—testicular cancer	0.000594	0.00162	CcSEcCtD
Acetylcysteine—Pruritus—Methotrexate—testicular cancer	0.00057	0.00155	CcSEcCtD
Acetylcysteine—GRIN1—Developmental Biology—MMP2—testicular cancer	0.00056	0.0012	CbGpPWpGaD
Acetylcysteine—Hypersensitivity—Epirubicin—testicular cancer	0.000556	0.00151	CcSEcCtD
Acetylcysteine—Urticaria—Doxorubicin—testicular cancer	0.000555	0.00151	CcSEcCtD
Acetylcysteine—CHUK—Innate Immune System—KITLG—testicular cancer	0.000553	0.00118	CbGpPWpGaD
Acetylcysteine—Body temperature increased—Doxorubicin—testicular cancer	0.000552	0.0015	CcSEcCtD
Acetylcysteine—GRIN2B—Developmental Biology—MMP2—testicular cancer	0.000546	0.00117	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—BCL10—testicular cancer	0.000534	0.00114	CbGpPWpGaD
Acetylcysteine—Pruritus—Epirubicin—testicular cancer	0.000534	0.00145	CcSEcCtD
Acetylcysteine—Dizziness—Methotrexate—testicular cancer	0.000533	0.00145	CcSEcCtD
Acetylcysteine—CHUK—Adaptive Immune System—KITLG—testicular cancer	0.000531	0.00114	CbGpPWpGaD
Acetylcysteine—Hypersensitivity—Doxorubicin—testicular cancer	0.000514	0.0014	CcSEcCtD
Acetylcysteine—Vomiting—Methotrexate—testicular cancer	0.000513	0.0014	CcSEcCtD
Acetylcysteine—Rash—Methotrexate—testicular cancer	0.000508	0.00139	CcSEcCtD
Acetylcysteine—Dermatitis—Methotrexate—testicular cancer	0.000508	0.00138	CcSEcCtD
Acetylcysteine—IKBKB—Innate Immune System—KITLG—testicular cancer	0.000502	0.00107	CbGpPWpGaD
Acetylcysteine—Dizziness—Epirubicin—testicular cancer	0.000499	0.00136	CcSEcCtD
Acetylcysteine—Pruritus—Doxorubicin—testicular cancer	0.000494	0.00135	CcSEcCtD
Acetylcysteine—IKBKB—Immune System—BCL10—testicular cancer	0.000485	0.00104	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—KITLG—testicular cancer	0.000482	0.00103	CbGpPWpGaD
Acetylcysteine—Vomiting—Epirubicin—testicular cancer	0.00048	0.00131	CcSEcCtD
Acetylcysteine—Nausea—Methotrexate—testicular cancer	0.000479	0.0013	CcSEcCtD
Acetylcysteine—Rash—Epirubicin—testicular cancer	0.000476	0.0013	CcSEcCtD
Acetylcysteine—Dermatitis—Epirubicin—testicular cancer	0.000475	0.0013	CcSEcCtD
Acetylcysteine—Dizziness—Doxorubicin—testicular cancer	0.000462	0.00126	CcSEcCtD
Acetylcysteine—Nausea—Epirubicin—testicular cancer	0.000448	0.00122	CcSEcCtD
Acetylcysteine—Vomiting—Doxorubicin—testicular cancer	0.000444	0.00121	CcSEcCtD
Acetylcysteine—Rash—Doxorubicin—testicular cancer	0.00044	0.0012	CcSEcCtD
Acetylcysteine—Dermatitis—Doxorubicin—testicular cancer	0.00044	0.0012	CcSEcCtD
Acetylcysteine—Nausea—Doxorubicin—testicular cancer	0.000415	0.00113	CcSEcCtD
Acetylcysteine—CHUK—Innate Immune System—FGFR3—testicular cancer	0.000411	0.00088	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—FGFR3—testicular cancer	0.000395	0.000845	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—KIT—testicular cancer	0.000378	0.000808	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—FGFR3—testicular cancer	0.000373	0.000798	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—KIT—testicular cancer	0.000363	0.000776	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—FGFR3—testicular cancer	0.000358	0.000766	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—KIT—testicular cancer	0.000342	0.000733	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—KIT—testicular cancer	0.000329	0.000704	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—H2AFZ—testicular cancer	0.000323	0.000692	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—KITLG—testicular cancer	0.000322	0.00069	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—HPGDS—testicular cancer	0.000311	0.000665	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—KITLG—testicular cancer	0.000298	0.000637	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—KITLG—testicular cancer	0.000292	0.000625	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—FGFR3—testicular cancer	0.00024	0.000513	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—H2AFZ—testicular cancer	0.000227	0.000485	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—STK11—testicular cancer	0.000226	0.000483	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—STK11—testicular cancer	0.000225	0.000482	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—FGFR3—testicular cancer	0.000221	0.000473	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—KIT—testicular cancer	0.00022	0.000471	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—FGFR3—testicular cancer	0.000217	0.000465	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KITLG—testicular cancer	0.000208	0.000446	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—H2AFZ—testicular cancer	0.000205	0.00044	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—STK11—testicular cancer	0.000204	0.000437	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—KIT—testicular cancer	0.000203	0.000435	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—KIT—testicular cancer	0.000199	0.000427	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KITLG—testicular cancer	0.000189	0.000404	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FGFR3—testicular cancer	0.000155	0.000331	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KIT—testicular cancer	0.000142	0.000304	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FGFR3—testicular cancer	0.00014	0.000301	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KIT—testicular cancer	0.000129	0.000276	CbGpPWpGaD
